Cellestia announces appointment of Florian D. Vogl, MD, PhD as Chief Medical Officer

Cellestia Biotech AG announces appointment of Florian D. Vogl, MD, PhD as Chief Medical Officer to advance the Clinical Development Program.

To read Cellestia’s press release click here.